Literature DB >> 26829623

In vivo platforms for analysis of HIV persistence and eradication.

J Victor Garcia.   

Abstract

HIV persistence in patients undergoing antiretroviral therapy is a major impediment to the cure of HIV/AIDS. The molecular and cellular mechanisms underlying HIV persistence in vivo have not been fully elucidated. This lack of basic knowledge has hindered progress in this area. The in vivo analysis of HIV persistence and the implementation of curative strategies would benefit from animal models that accurately recapitulate key aspects of the human condition. This Review summarizes the contribution that humanized mouse models of HIV infection have made to the field of HIV cure research. Even though these models have been shown to be highly informative in many specific areas, their great potential to serve as excellent platforms for discovery in HIV pathogenesis and treatment has yet to be fully developed.

Entities:  

Mesh:

Year:  2016        PMID: 26829623      PMCID: PMC4731180          DOI: 10.1172/JCI80562

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  110 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

2.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

5.  Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year.

Authors:  Bradford K Berges; Sarah R Akkina; Leila Remling; Ramesh Akkina
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

Review 6.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

7.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.

Authors:  Martina Kovarova; Olivia D Council; Abhijit A Date; Julie M Long; Tomonori Nochi; Tomonori Nochii; Michael Belshan; Annemarie Shibata; Heather Vincent; Caroline E Baker; William O Thayer; Guenter Kraus; Sophie Lachaud-Durand; Peter Williams; Christopher J Destache; J Victor Garcia
Journal:  PLoS Pathog       Date:  2015-08-13       Impact factor: 6.823

9.  Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Jun Lai; Stanley Chioma; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

10.  Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice.

Authors:  Morgan L Chateau; Paul W Denton; Michael D Swanson; Ian McGowan; J Victor Garcia
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more
  14 in total

1.  Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa.

Authors:  Maud Deruaz; Thomas T Murooka; Sophina Ji; Marc A Gavin; Vladimir D Vrbanac; Judy Lieberman; Andrew M Tager; Thorsten R Mempel; Andrew D Luster
Journal:  JCI Insight       Date:  2017-04-06

2.  Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.

Authors:  Drake J Smith; Levina J Lin; Heesung Moon; Alexander T Pham; Xi Wang; Siyuan Liu; Sunjong Ji; Valerie Rezek; Saki Shimizu; Marlene Ruiz; Jennifer Lam; Deanna M Janzen; Sanaz Memarzadeh; Donald B Kohn; Jerome A Zack; Scott G Kitchen; Dong Sung An; Lili Yang
Journal:  Stem Cells Dev       Date:  2016-10-18       Impact factor: 3.272

Review 3.  Animal models to achieve an HIV cure.

Authors:  Nitasha Kumar; Ann Chahroudi; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

4.  In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

Authors:  Cari F Kessing; Christopher C Nixon; Chuan Li; Perry Tsai; Hiroshi Takata; Guillaume Mousseau; Phong T Ho; Jenna B Honeycutt; Mohammad Fallahi; Lydie Trautmann; J Victor Garcia; Susana T Valente
Journal:  Cell Rep       Date:  2017-10-17       Impact factor: 9.423

Review 5.  Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice.

Authors:  Lishan Su
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

Review 6.  Humanized mice for HIV and AIDS research.

Authors:  J Victor Garcia
Journal:  Curr Opin Virol       Date:  2016-07-19       Impact factor: 7.090

Review 7.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

Review 8.  Curing HIV: Seeking to Target and Clear Persistent Infection.

Authors:  David M Margolis; Nancie M Archin; Myron S Cohen; Joseph J Eron; Guido Ferrari; J Victor Garcia; Cynthia L Gay; Nilu Goonetilleke; Sarah B Joseph; Ronald Swanstrom; Anne-Marie W Turner; Angela Wahl
Journal:  Cell       Date:  2020-03-26       Impact factor: 41.582

9.  T cells establish and maintain CNS viral infection in HIV-infected humanized mice.

Authors:  Jenna B Honeycutt; Baolin Liao; Christopher C Nixon; Rachel A Cleary; William O Thayer; Shayla L Birath; Michael D Swanson; Patricia Sheridan; Oksana Zakharova; Francesca Prince; JoAnn Kuruc; Cynthia L Gay; Chris Evans; Joseph J Eron; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2018-06-04       Impact factor: 14.808

Review 10.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.